AU2003226509A1 - Use of devazepide for the treatment of constipation - Google Patents

Use of devazepide for the treatment of constipation

Info

Publication number
AU2003226509A1
AU2003226509A1 AU2003226509A AU2003226509A AU2003226509A1 AU 2003226509 A1 AU2003226509 A1 AU 2003226509A1 AU 2003226509 A AU2003226509 A AU 2003226509A AU 2003226509 A AU2003226509 A AU 2003226509A AU 2003226509 A1 AU2003226509 A1 AU 2003226509A1
Authority
AU
Australia
Prior art keywords
devazepide
constipation
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003226509A
Inventor
Karen Jackson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Innovata Ltd
Original Assignee
ML Laboratories PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ML Laboratories PLC filed Critical ML Laboratories PLC
Publication of AU2003226509A1 publication Critical patent/AU2003226509A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2003226509A 2002-03-26 2003-03-26 Use of devazepide for the treatment of constipation Abandoned AU2003226509A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0207091.0A GB0207091D0 (en) 2002-03-26 2002-03-26 Method of treatment
GB0207091.0 2002-03-26
PCT/GB2003/001285 WO2003080066A1 (en) 2002-03-26 2003-03-26 Use of devazepide for the treatment of constipation

Publications (1)

Publication Number Publication Date
AU2003226509A1 true AU2003226509A1 (en) 2003-10-08

Family

ID=9933725

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003226509A Abandoned AU2003226509A1 (en) 2002-03-26 2003-03-26 Use of devazepide for the treatment of constipation

Country Status (3)

Country Link
AU (1) AU2003226509A1 (en)
GB (1) GB0207091D0 (en)
WO (1) WO2003080066A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006094434A1 (en) * 2005-03-10 2006-09-14 Maoji Zheng Non-invading type of assistant defecting device by means of suction trough air bleeding and pressure reduction

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995032963A1 (en) * 1994-06-01 1995-12-07 Yoshitomi Pharmaceutical Industries, Ltd. Thienylazole compound and thienotriazolodiazepine compound
US5457101A (en) * 1994-06-03 1995-10-10 Eli Lilly And Company Thieno[1,5]benzoidiazepine use
GB9721746D0 (en) * 1997-10-15 1997-12-10 Panos Therapeutics Limited Compositions

Also Published As

Publication number Publication date
GB0207091D0 (en) 2002-05-08
WO2003080066A1 (en) 2003-10-02

Similar Documents

Publication Publication Date Title
AU2003249244A1 (en) Methods for the treatment of neoplasms
AU2003217870A1 (en) Pini-modulating compounds and methods of use thereof
AU2003225668A1 (en) Pin1-modulating compounds and methods of use thereof
AU2003225669A1 (en) Pin1-modulating compounds and methods of use thereof
AU2935200A (en) Compounds for the treatment of obesity
AU2003213673A1 (en) Pin1-modulating compounds and methods of use thereof
AU2003300791A1 (en) Combination therapy for the treatment of pain
AU2003279442A1 (en) 2-thiohydantoine derivative compounds and use thereof for the treatment of diabetes
ZA200501288B (en) Substituted 5-chroman-5-yl-ethylamine compounds and their use for the treatment of glaucoma.
AU2003212634A1 (en) Compounds useful in the treatment of cancer
AU2003290059A1 (en) Use of cd137 antagonists for the treatment of tumors
AU2003257577A1 (en) Sponge prophy
AU2001228703A1 (en) Use of cox-2 inhibitors for the treatment of constipation
AU2003247005A1 (en) Therapy combination
AU2003251875A1 (en) Combination therapy for the treatment of neoplasms
AU2003251904A1 (en) Combinations of drugs for the treatment of neoplasms
AU2003245794A1 (en) Glycosaminoglycan-dnase combination therapy
AU2003294817A1 (en) Sanitary fitting
AU2003223538A1 (en) Methods for the treatment of cancer
AU2003291368A1 (en) Compounds for the treatment of tobacco dependence and withdrawal
AU2003266965A1 (en) Use of carboxamides for the treatment of tinnitus
AU2003270683A1 (en) Compounds for the treatment of premature ejaculation
AU2003296545A1 (en) Use of a trpm8-activating substance for the treatment of tumours
AU2003226509A1 (en) Use of devazepide for the treatment of constipation
AU2004281077A1 (en) Methods and agents for the treatment of cancer

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase